Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells.
about
Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseShort-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis: Efficacy of 7 targeted therapies for AHCC.Reactive oxygen species and autophagy modulation in non-marine drugs and marine drugs.Multiple mechanisms mediate resistance to sorafenib in urothelial cancerKnockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicinCombining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer.Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association studyDroxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and Downregulation of FLIP.Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis.Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells.Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo.The role of autophagy in hepatocellular carcinoma: friend or foe.Cell death-based treatment of lung adenocarcinoma.Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
P2860
Q26739760-42AD303D-33A3-4AF8-A27A-29119B516EA1Q26745320-4D4F63C8-2AA8-4CDC-A2D4-2C11451CF359Q30240170-0D289297-2A4A-4E7E-9B90-7497F99991E1Q34577847-6D838374-169A-4083-98F2-B1068053FD8DQ34685436-733C0C76-C73B-4262-B092-DCF0079BDE3CQ35159686-72BAEE16-85CB-410E-A24E-906A83F48BA9Q35728238-A85955C8-EFFD-4078-A23C-C8CF8D51D6C8Q36211604-8361F843-913F-4507-A93B-F91B5039015BQ36707143-2A0EF27A-595A-4DC7-A30D-C434193B8FFEQ37322455-05D146FE-2740-4E08-BA14-94EC355875C0Q37368670-9C3B50D9-C09D-4E74-AFD5-DFE964469925Q37413127-A02C1EF2-C112-4EF0-BDDE-54A5B68D26ADQ38604581-C2559A33-6C0F-4DF8-97CC-81B42A40BDE0Q41339988-9734E608-1ABC-4E8A-9583-40DCE1CB1C5EQ47711273-4A508E30-FC9E-49CD-8117-C7129D13AA16Q53696566-EE81527A-D3DE-470C-8504-5D20BEBBB139Q59132751-F389F02E-4C58-4EDB-821C-D5A5FFA20079
P2860
Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Inhibition of autophagy signifi ...... tors for human hepatoma cells.
@en
Inhibition of autophagy signifi ...... tors for human hepatoma cells.
@nl
type
label
Inhibition of autophagy signifi ...... tors for human hepatoma cells.
@en
Inhibition of autophagy signifi ...... tors for human hepatoma cells.
@nl
prefLabel
Inhibition of autophagy signifi ...... tors for human hepatoma cells.
@en
Inhibition of autophagy signifi ...... tors for human hepatoma cells.
@nl
P2093
P2860
P356
P1476
Inhibition of autophagy signifi ...... tors for human hepatoma cells.
@en
P2093
Long-Jiu Cui
Meng-Chao Wu
Sen-Lin Ma
P2860
P304
P356
10.3748/WJG.V20.I17.4953
P407
P577
2014-05-01T00:00:00Z